This page shows the publications co-authored by James Markmann and Omar Haque.
Thrombolytic Therapy During ex-vivo Normothermic Machine Perfusion of Human Livers Reduces Peribiliary Vascular Plexus Injury. Front Surg. 2021; 8:644859.
Evolving utilization of donation after circulatory death livers in liver transplantation: The day of DCD has come. Clin Transplant. 2021 03; 35(3):e14211.
The effect of blood cells retained in rat livers during static cold storage on viability outcomes during normothermic machine perfusion. Sci Rep. 2021 11 30; 11(1):23128.
The Heterogenous Effect of COVID-19 on Liver Transplantation Activity and Waitlist Mortality in the United States. Front Surg. 2021; 8:669129.
Twenty-four hour ex-vivo normothermic machine perfusion in rat livers. Technology (Singap World Sci). 2020 Mar-Jun; 8(1-2):27-36.
Heterogeneity in transplant center responses to the minimum acceptance criteria across UNOS regions. Clin Transplant. 2022 Mar; 36(3):e14551.
Influence of donor and recipient hepatitis B virus infection on long-term outcomes after kidney transplantation. Clin Transplant. 2021 12; 35(12):e14466.
The impact of race and comorbid conditions on adult liver transplant outcomes in obese recipients. Transpl Int. 2021 12; 34(12):2834-2845.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.